विवरण
A CONSORT flow diagram details participant enrollment, randomization, and retention through the 6-month anti-inflammatory diet trial in ulcerative colitis patients in clinical remission.
Figure 6
FlowchartSource Paper
Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Metabolomic Profile of Ulcerative Colitis Patients in Clinical Remission.Cite This Figure
![Figure 6: A CONSORT flow diagram details participant enrollment, randomization, and retention through the 6-month anti-inflammatory diet trial in ulcerative colitis patients in clinical remission.]() > Source: Ammar Hassanzadeh Keshteli et al. "Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Meta." *Nutrients*, 2022. PMID: [36014800](https://pubmed.ncbi.nlm.nih.gov/36014800/)
<figure> <img src="" alt="A CONSORT flow diagram details participant enrollment, randomization, and retention through the 6-month anti-inflammatory diet trial in ulcerative colitis patients in clinical remission." /> <figcaption>Figure 6. A CONSORT flow diagram details participant enrollment, randomization, and retention through the 6-month anti-inflammatory diet trial in ulcerative colitis patients in clinical remission.<br> Source: Ammar Hassanzadeh Keshteli et al. "Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Meta." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36014800/">36014800</a></figcaption> </figure>